Related Articles
Facial nerve injury immune‑related adverse events associated with adjuvant pembrolizumab therapy: A case report
Toxicity, disease management and outcome of treatment with immune checkpoint inhibitors by sex in patients with cancer and preexisting autoimmune disease
Musculoskeletal adverse reactions after immunotherapy for cancer: A case series
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)
Diabetes insipidus: A rare endocrine complication of immune check point inhibitors: A case report and literature review